Itamar™ Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence

    NEXT STORY
    SIGA Announces Collaboration with Turnstone Biologics
    PREV STORY
    BC researchers secure $10M in funding to examine the effectiveness of genomics in clinical health care
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ultragenyx and Kyowa Hakko Kirin Announce Submission of Burosumab’s Biologics License Application in the US

    NOVATO, Calif. and TOKYO, Aug. 24, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), ...

    author_avatar
    NASDAQ Market News

    QuestCap Closes Transaction to Acquire 30% Interest in Glenco Medical

    author_avatar
    NASDAQ Market News

    Agios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiency

    author_avatar
    NASDAQ Market News